Sanofi SA (SNYNF)
99.25
-2.25
(-2.22%)
USD |
OTCM |
May 09, 16:00
Sanofi Price to Book Value: 1.514 for May 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 09, 2024 | 1.514 |
May 08, 2024 | 1.548 |
May 07, 2024 | 1.548 |
May 06, 2024 | 1.474 |
May 03, 2024 | 1.525 |
May 02, 2024 | 1.525 |
May 01, 2024 | 1.525 |
April 30, 2024 | 1.457 |
April 29, 2024 | 1.457 |
April 26, 2024 | 1.457 |
April 25, 2024 | 1.457 |
April 24, 2024 | 1.434 |
April 23, 2024 | 1.437 |
April 22, 2024 | 1.414 |
April 19, 2024 | 1.414 |
April 18, 2024 | 1.414 |
April 17, 2024 | 1.414 |
April 16, 2024 | 1.405 |
April 15, 2024 | 1.418 |
April 12, 2024 | 1.417 |
April 11, 2024 | 1.417 |
April 10, 2024 | 1.437 |
April 09, 2024 | 1.438 |
April 08, 2024 | 1.434 |
April 05, 2024 | 1.414 |
Date | Value |
---|---|
April 04, 2024 | 1.466 |
April 03, 2024 | 1.489 |
April 02, 2024 | 1.489 |
April 01, 2024 | 1.489 |
March 31, 2024 | |
March 28, 2024 | 1.489 |
March 27, 2024 | 1.521 |
March 26, 2024 | 1.524 |
March 25, 2024 | 1.524 |
March 22, 2024 | 1.429 |
March 21, 2024 | 1.452 |
March 20, 2024 | 1.447 |
March 19, 2024 | 1.447 |
March 18, 2024 | 1.447 |
March 15, 2024 | 1.479 |
March 14, 2024 | 1.479 |
March 13, 2024 | 1.479 |
March 12, 2024 | 1.479 |
March 11, 2024 | 1.479 |
March 08, 2024 | 1.440 |
March 07, 2024 | 1.440 |
March 06, 2024 | 1.440 |
March 05, 2024 | 1.428 |
March 04, 2024 | 1.428 |
March 01, 2024 | 1.441 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.241
Minimum
Sep 23 2022
2.040
Maximum
Jun 23 2020
1.667
Average
1.676
Median
Oct 07 2021
Price to Book Value Benchmarks
DBV Technologies SA | 0.8010 |
Cellectis SA | 2.651 |
PHAXIAM Therapeutics SA (DELISTED) | 0.4731 |
Genfit SA | 2.483 |
Price to Book Value Related Metrics
PE Ratio | 25.08 |
PS Ratio | 2.451 |
Price | 99.25 |
Earnings Yield | 3.99% |
Market Cap | 123.89B |
Operating PE Ratio | 11.67 |
Normalized PE Ratio | 16.77 |